In Section A, contributors will receive distinctive doses and schedules of oral ABBV-744 tablet to discover Secure dosing routine. Supplemental individuals are going to be enrolled on the determined monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Phase https://abbv-744-safety-and-side02457.webbuzzfeed.com/32484490/considerations-to-know-about-abbv-744-brd4-inhibitor-cancer-therapy-efficacy